AbbVie registers Phase 3 trial of etentamig vs Dara-CyBorD in AL amyloidosisAug 28Trial updateAbbViedexamethasone
Nexcella registers Phase 3 NEXICART-3 trial of CAR-T NXC-201 in AL amyloidosisJul 16Trial updateImmix Biopharma, Inc.
Sign inSign in